Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid Clinical Trial (FACT)
2012-001918-42Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Folic acid 4 mg with Placebo (2 arms). Primary endpoint: Preeclampsia incidence. Started Jul 2020; status: completed.
02
Drugs
folic acid
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2012-001918-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001918-42.